NUCALA (mepolizumab) for injection NUCALA (mepolizumab ...

17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. _____ 2 . FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . 1.1 Maintenance Treatment of Severe Asthma . NUCALA is indicated for the add-on maintenance treatment of adult and pediatric patients aged ...

  Information, Patients

Zejula (niraparib) capsules - GSKpro

17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. 2 _____ FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . 1.1 First-Line Maintenance Treatment of Advanced Ovarian Cancer . ZEJULA is indicated for the maintenance treatment of adult patients with advanced epithelial ...

  Information, Patients, Niraparib

LAMICTAL (lamotrigine) Tablets LAMICTAL (lamotrigine ...

could cause serious arrhythmias and/or death in patients with certain underlying cardiac disorders or arrhythmias. Any expected or observed benefit of LAMICTAL in an individual patient with clinically important structural or functional heart disease must be carefully weighed against the risk for serious arrythmias and/or death for that patient .

  Cardiac, Serious, Arrhythmia, Serious arrhythmias

JEMPERLI (dostarlimab-gxly) injection

• Complications of allogeneic hematopoietic stem cell transplantation (HSCT): Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1–blocking antibody. (5.3) • Embryo-fetal toxicity: Can cause fetal harm. Advise females of

  Fetal, Cells

BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and ...

• The tip caps of the prefilled syringes contain natural rubber latex which may cause allergic reactions. (5.2) ... whenever solution and container permit. Do not use the vaccine if either ... BOOSTRIX is a suspension for injection available in 0.5-mL single-dose vials and prefilled

  Solutions, Rubber, Suspension

ZENTEL® Albendazol 200 mg Tabletas

ZENTEL® está contraindicado durante el embarazo, y durante un mes antes de la concepción. Con el fin de evitar la administración de albendazol durante el embarazo precoz, las mujeres en edad fértil deben iniciar el tratamiento durante la primera semana de la menstruación o después de una prueba de embarazo negativa. 4 . RD N°22158-2015 2da.

ZYRTEC ORAL DROPS 10 mg/ml ZYRTEC ORAL SOLUTION 1 …

Cetirizine dihydrochloride, a metabolite of hydroxyzine, is an anti-allergic agent, with a histamine H 1 receptor antagonism devoid of any significant anticholinergic and antiserotonin effects as demonstrated in experimental and clinical pharmacology.

  Oral, Histamine, Zyrtec, Zyrtec oral

ゼビュディ点滴静注 調製・投与方法のご案内

5）Fadini GP, et al. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 2020. 6）Zheng Z, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.

  Finaid

GSKPro for Healthcare Professionals

Priming VENTOLIN HFA is essential to ensure appropriate albuterol content in each actuation. Prime VENTOLIN HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped. To prime VENTOLIN HFA, release 4 sprays into the air away f rom the face, shaking well before each spray.

  Inhaler, Ventolin, Ventolin hfa

Guía para el uso racional de antibióticos

O’Neil J.Tackling drug-resistant infections globally: fi nal report and recommendations. Chaired by Jim O` Neil.[Internet] Mayo 2016. [Último acceso: junio 2018].

  Tackling

ORENCIA Patient Information - BMS

General information about the safe and effective use of ORENCIA. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ORENCIA for a condition for which it was not prescribed. Do not give ORENCIA to other people, even if they have the same symptoms that you have. It may harm them.

  Information, Patients, Patient information, Raciones, Orencia patient information

PATIENT INFORMATION - epipen.com

This Patient Information Leaflet summarizes the most important information about the EpiPen and EpiPen Jr Auto-Injectors. If you would like more information, talk to your healthcare provider. You can ask your pharmacist or healthcare provider for information about the EpiPen and EpiPen Jr Auto-Injector that is written for health professionals.

  Information, Patients, Patient information

HIGHLIGHTS OF PRESCRIBING INFORMATION • These …

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling Revised: 7/2021 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1. Dosing Over Time 2.2. Insertion Instructions 2.3 Patient Follow-up 2.4 Removal of Skyla 2.5 Continuation of Contraception after Removal 3 …

  Information, Patients

MIRENA is small

Patient Information MIRENA® (mur-ā-nah) (levonorgestrel-releasing intrauterine system) Read this Patient Information carefully before you decide if MIRENA is right for you. This information does not take the place of talking with your gynecologist or other healthcare provider who specializes in …

  Information, Patients, Patient information

CALQUENCE PRESCRIBING INFORMATION

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 11/2019 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Mantle Cell Lymphoma 1.2 Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 …

  Information, Patients, Prescribing, Prescribing information

HIGHLIGHTS OF PRESCRIBING INFORMATION …

See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 03/2021 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 Dosage Modifications 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 6 ADVERSE …

  Information, Patients, Prescribing, Prescribing information

AUTHORIZATION TO RELEASE COPIES OF A MEDICAL RECORD

Myself: I request Michigan Medicine to release my protected health information to Myself to the address listed above. Select delivery method: MyUofMHealth.orgPortal Electronic (Patient email web link) US Mail Other:3.I am the patient, or the legally authorized representative of the patient listed above and request Michigan Medicine to

  Information, Patients, Medicine, Michigan, Michigan medicine

ADAKVEO. ADAKVEO HIGHLIGHTS OF PRESCRIBING …

Pregnancy: May cause fetal harm. (See 17 for PATIENT COUNSELING INFORMATION and FDA-8.1) approved patient labeling. Revised: 7/2021 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 Preparation and Administration 2.3 Management of Infusion …

  Information, Patients, Prescribing, Prescribing information

HIGHLIGHTS OF PRESCRIBING INFORMATION …

[see Patient Counseling Information (17)]. Do not take more than one dose in 24 hours. For administration of SPIRIVA HANDIHALER, a SPIRIVA capsule is placed into the center chamber of the HANDIHALER device. The SPIRIVA capsule is pierced by pressing and releasing the green piercing button on the side of the HANDIHALER device.

  Information, Patients

NUCALA (mepolizumab) for injection NUCALA ... - GSKpro

A patient may self-inject or the patient caregiver may administer NUCALA injection 100 mg/mL subcutaneously after the healthcare provider determines it is appropriate. The 40-mg/0.4-mL prefilled syringe is only for use in children aged 6 to 11 years and must be administered by the healthcare provider or the patient caregiver.

  Patients